Aravax is a clinical-stage biotechnology company developing the first safe and rapidly effective treatment for peanut allergy.
Clinical Trials
Clinical trial AVX-001 is the first study of PVX108 to be conducted in humans.
Developing a safe, disease-modifying treatment for peanut allergy